Midwifery

Homecare Pregnancy Test Kits Market to Reach USD 1391.8 Million By 2027 | Reports And Data

Wednesday, June 3, 2020 - 7:00pm

NEW YORK, June 3, 2020 /PRNewswire/ -- The global homecare pregnancy test kit market is forecast to reach USD 1391.8 million in 2027, according to a new report by Reports and Data.

Key Points: 
  • NEW YORK, June 3, 2020 /PRNewswire/ -- The global homecare pregnancy test kit market is forecast to reach USD 1391.8 million in 2027, according to a new report by Reports and Data.
  • The global homecare pregnancy test kit market is growing at a substantial pace owing to the growing acceptance and inclination of the patients towards the newly invented advanced testing kits over the conventional ones.
  • To identify the key trends in the industry, click on the link below:
    The North America homecare pregnancy test kits market is anticipated to dominate the in the global market.
  • For the purpose of this report, Reports and Data have segmented into the global homecare pregnancy test kit market on the basis of Type of test, product, sales channel, and region:
    Type of test Outlook (Revenue, USD Billion; 2017-2027)

Homecare Pregnancy Test Kits Market to Reach USD 1391.8 Million By 2027 | Reports And Data

Wednesday, June 3, 2020 - 7:00pm

The global homecare pregnancy test kit market is growing at a substantial pace owing to the growing acceptance and inclination of the patients towards the newly invented advanced testing kits over the conventional ones.

Key Points: 
  • The global homecare pregnancy test kit market is growing at a substantial pace owing to the growing acceptance and inclination of the patients towards the newly invented advanced testing kits over the conventional ones.
  • Besides, the increase in healthcare expenditure and increasing demand for self-contained and quick test results coupled with the increasing age of women having first pregnancy are propelling the market growth.
  • To identify the key trends in the industry, click on the link below:
    The North America homecare pregnancy test kits market is anticipated to dominate the in the global market.
  • For the purpose of this report, Reports and Data have segmented into the global homecare pregnancy test kit market on the basis of Type of test, product, sales channel, and region:
    Type of test Outlook (Revenue, USD Billion; 2017-2027)

FDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women

Friday, May 29, 2020 - 9:14pm

"This approval provides women with a non-surgical option to help address unresolved heavy menstrual bleeding in an impactful way."

Key Points: 
  • "This approval provides women with a non-surgical option to help address unresolved heavy menstrual bleeding in an impactful way."
  • "ORIAHNN signifies an important advance in how we can care for women with uterine fibroids."
  • "The FDA's approval of an oral treatment for women suffering from heavy menstrual bleeding due to uterine fibroids marks a step forward in women's health.
  • ORIAHNN can decrease your menstrual bleeding or result in no menstrual bleeding at all, making it hard to know if you are pregnant.

FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women

Friday, May 29, 2020 - 5:08pm

Various non-surgical therapies are used to treat fibroid-related heavy menstrual bleeding, but none have been FDA-approved specifically for this use.

Key Points: 
  • Various non-surgical therapies are used to treat fibroid-related heavy menstrual bleeding, but none have been FDA-approved specifically for this use.
  • Fibroids are benign (non-cancerous) muscle tumors of the uterus that can cause heavy menstrual bleeding, pain, bowel or bladder problems and infertility.
  • Some women may not experience any symptoms, but many do, including heavy bleeding with periods.
  • Heavy menstrual bleeding at baseline was defined as having at least two menstrual cycles with greater than 80 mL (about a third of a cup) of menstrual blood loss (MBL).

Around the Clock Healthcare Services (ATC) to Offer Turn-Key Onsite COVID-19 Testing Services to All Businesses

Friday, May 29, 2020 - 1:31pm

Today, rising unemployment, repairing the economy, re-opening business, and bringing back workforces safely, including through the utilizations of various testing options, are key topic's in today's news cycle.

Key Points: 
  • Today, rising unemployment, repairing the economy, re-opening business, and bringing back workforces safely, including through the utilizations of various testing options, are key topic's in today's news cycle.
  • By partnering with ATC, businesses will be able to ensure a safe and healthy work environment for their employees without incurring the unnecessary burden of coordinating testing.
  • ATC has taken the steps to invest in those resources that are necessary to provide this comprehensive and unique quality testing solution.
  • Screening: ATC is providing comprehensive screening services to ensure that employees are safe to come into the work place on a daily basis.

Resuming Deferred Procedures Will be Complex as Health Systems Work to Mitigate Concerns, Deloitte Survey Finds

Wednesday, May 27, 2020 - 3:00pm

Survey respondents say their organizations are planning or implementing measures to mitigate key concerns.

Key Points: 
  • Survey respondents say their organizations are planning or implementing measures to mitigate key concerns.
  • Of note, 88% have partially or fully implemented and 10% are planning to implement use of virtual health for some or all non-procedure visits.
  • Clinical leaders expect getting back to pre-COVID-19 volumes could take between two and six months.
  • Notably, nearly all leaders said their organizations have implemented or plan to use virtual health for non-procedure visits.

Novagen Is Proud to Offer Top DNA Testing Services for The People of Vietnam

Tuesday, May 26, 2020 - 3:00pm

DNA testing is the process of verifying a blood relationship between two people by comparing specific DNA markers in each person's genome.

Key Points: 
  • DNA testing is the process of verifying a blood relationship between two people by comparing specific DNA markers in each person's genome.
  • Novagen is offering DNA testing services that focus on gene identification services, DNA testing, prenatal DNA testing, genetic testing and NIPT noninvasive prenatal screening.
  • The Novagen testing laboratory is meeting the ISO 9001: 2015 standard and is the first company to apply 27 loci testing technology in DNA testing.
  • Customers of Novagen can access various types of testing and services such as DNA tests for father and son, DNA test for the birth certificate, DNA tests for illegitimate son, prenatal DNA test, non-invasive fetal DNA test , DNA tests for mother and children, DNA testing for Bowel DNA, DNA tests for grandparents and grandchildren, DNA tests for relatives, screening for non-invasive birth defects, sequencing of new generation NGS gene.

COVID-19 Crisis: Aetna Expands NIPT Coverage for Young Pregnant Women

Monday, May 18, 2020 - 7:00pm

While Aetna has taken an encouraging step towards safeguarding maternal health during the COVID-19 pandemic, Stand Up!

Key Points: 
  • While Aetna has taken an encouraging step towards safeguarding maternal health during the COVID-19 pandemic, Stand Up!
  • women under the age of 35, big players like Aetna and UnitedHealthcare (UHC) still restrict coverage to include only traditional serum screening and other similar tests for young pregnant women.
  • By limiting NIPT access to women over the age of 35, these insurers in-effect put young women at high risk of false positives and false negatives.
  • 4APA, a non-profit organization, has raised awareness against the age-related discrimination amongst pregnant women that deprives access to the advanced and accurate NIPTs for young moms-to-be.

Preeclampsia Foundation Leads Effort to Mobilize Blood Pressure Cuffs to Enable Telehealth Care for Pregnant and Postpartum Women

Tuesday, May 19, 2020 - 1:39pm

MELBOURNE, Fla., May 19, 2020 /PRNewswire/ --The Preeclampsia Foundation is responding to the needs of pregnant and postpartum women, during COVID-19, with the introduction of The Cuff Kit.

Key Points: 
  • MELBOURNE, Fla., May 19, 2020 /PRNewswire/ --The Preeclampsia Foundation is responding to the needs of pregnant and postpartum women, during COVID-19, with the introduction of The Cuff Kit.
  • With women's obstetric care being monitored by telehealth or otherwise impacted by restrictions and access to care, the Foundation is partnering with healthcare leaders and funders to equip women with home blood pressure monitoring devices and educational material.
  • The Foundation recommends keeping up with prenatal and postpartum visits that include blood pressure monitoring and a review of the signs and symptoms for preeclampsia.
  • There, pregnant and new moms can download blank logs or learn about blood pressure tracking apps, watch video tutorials, and receive other information related to blood pressure and their health.

New Study Finds Nutritional Supplement Jubilance Relieves PMS Mood Symptoms

Thursday, May 14, 2020 - 10:42pm

SAN DIEGO, May 14, 2020 /PRNewswire/ -- Terra Biological LLC reports a new study , peer-reviewed and published by the Journal of Obstetrics and Gynecology Science, finds that daily usage of Jubilance , an over-the-counter nutritional supplement containing oxaloacetate (OAA), significantly relieves Premenstrual Syndrome (PMS)-related mood symptoms within the first menstrual cycle.

Key Points: 
  • SAN DIEGO, May 14, 2020 /PRNewswire/ -- Terra Biological LLC reports a new study , peer-reviewed and published by the Journal of Obstetrics and Gynecology Science, finds that daily usage of Jubilance , an over-the-counter nutritional supplement containing oxaloacetate (OAA), significantly relieves Premenstrual Syndrome (PMS)-related mood symptoms within the first menstrual cycle.
  • The randomized, double-blinded, placebo-controlled study led by Lisa Tully, Ph.D., reports that the four core mood symptoms associated with PMS, anxiety, irritability, stress and gloomy mood, were all significantly reduced compared to placebo after daily intake of Jubilance.
  • "This important finding, to be able to reduce the severity of mood symptoms, is exciting for doctors and women sick of dealing with the monthly struggle.
  • Researchers theorize that Jubilance relieves PMS-related mood symptoms by improving glucose metabolism in both the brain and body.